BTIG Upgrades GE HealthCare Techs to Buy, Announces $100 Price Target
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Ryan Zimmerman has upgraded GE HealthCare Techs (NASDAQ:GEHC) from Neutral to Buy, setting a price target of $100.
September 18, 2024 | 11:24 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BTIG analyst Ryan Zimmerman has upgraded GE HealthCare Techs from Neutral to Buy, with a new price target of $100, indicating a positive outlook for the stock.
The upgrade from Neutral to Buy by BTIG, along with a $100 price target, suggests increased confidence in GE HealthCare Techs' future performance. This is likely to positively influence investor sentiment and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100